Evidence map›Paper›PMID 41750313›Full record

ArticleBiomolecules2026

Membrane-Mediated Nanoassembly of Lysozyme-Tannic Acid for Crystallization-Suppressed Nobiletin Delivery: Enhanced Cellular Uptake and Mucus Penetration.

Hongyu Liang, Jiahao Xing, Qiuyue Hou, Luyang Bao, Bin Li, Bin Zhou, Hongshan Liang

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongyu LiangCooperative Innovation Center of Industrial Fermentation, School of Life and Health Sciences, Hubei University of Technology, Ministry of Education & Hubei Province, Wuhan 430068, China.
Jiahao XingCollege of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
Qiuyue HouCooperative Innovation Center of Industrial Fermentation, School of Life and Health Sciences, Hubei University of Technology, Ministry of Education & Hubei Province, Wuhan 430068, China.
Luyang BaoCooperative Innovation Center of Industrial Fermentation, School of Life and Health Sciences, Hubei University of Technology, Ministry of Education & Hubei Province, Wuhan 430068, China.
Bin LiCollege of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.ORCID 0000-0001-7763-4245
Bin ZhouCooperative Innovation Center of Industrial Fermentation, School of Life and Health Sciences, Hubei University of Technology, Ministry of Education & Hubei Province, Wuhan 430068, China.ORCID 0000-0002-2839-4967
Hongshan LiangCollege of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.

Funding

lianghongshan 2023QNRC001lianghongshan 32172354zhoubin 2662024SPPY003
6 · The paper itself

Abstract

To enhance the bioavailability of hydrophobic nobiletin (NOB), this study constructed nanoparticles (LT-NOB) via self-assembly of lysozyme and tannic acid (TA). The multivalent weak interaction network between TA and lysozyme effectively encapsulated amorphous NOB, inhibiting crystallization. The optimized LT-NOB exhibited a size of 212 nm, high encapsulation efficiency (89.5%), and drug loading (47.25%). Cellular uptake was significantly improved, primarily through macropinocytosis, followed by lysosomal escape and endoplasmic reticulum targeting. In Caco-2 and co-culture models, LT-NOB enhanced mucosal permeation by 75% and 50%, respectively, compared to free NOB. This work elucidates a robust strategy for stabilizing amorphous drugs and promoting their intestinal absorption, providing a foundation for advanced nanodrug delivery.

Indexed as

FlavonesMucusMuramidaseNanoparticlesTanninsAnimalsCaco-2 CellsCrystallizationHumansPolyphenolsFlavonesMuramidasenobiletinPolyphenolstannic acidTanninsintracellular transportlysozymenobiletinself-assemblytannic acid

Identifiers

PMID41750313
PMCPMC12938187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.